カテゴリー： MarketsandMarkets, 世界, 医療/バイオ

世界のマウスモデル市場（～2029年）：モデルタイプ別（近交系、異系交配、ハイブリッド）、サービス別（育種、再誘導）、技術別（マイクロインジェクション、CRISPR/Cas9）、治療分野別（腫瘍、神経、免疫）、用途別（研究、創薬）

◆英語タイトル：Mice Model Market by Model Types (Inbred, Outbred, Hybrid), Services (Breeding, Rederivation), Technology (Microinjection, CRISPR/Cas9), Therapeutic Area (Oncology, Neurology, Immunology), Application (Research, Drug Discovery) - Global Forecast to 2029
	◆商品コード：BT2192-24 ◆発行会社（リサーチ会社）：MarketsandMarkets ◆発行日：2024年2月 ◆ページ数：369 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後24時間以内） ◆調査対象地域：グローバル ◆産業分野：バイオ

◆販売価格オプション（消費税別）

Single User（1名様閲覧）	USD4,950 ⇒換算￥752,400	見積依頼/購入/質問フォーム
Multi User (Five User)	USD6,650 ⇒換算￥1,010,800	見積依頼/購入/質問フォーム
Corporate License (全社内共有可)	USD8,150 ⇒換算￥1,238,800	見積依頼/購入/質問フォーム

★MarketsandMarketsに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

“マウスモデル市場は、予測期間中の年平均成長率8.1%で、2024年の推定15億米ドルから2029年には22億米ドルに達すると予測”この市場の成長は、新規治療法の創薬・開発を目的とした研究開発努力と研究におけるマウスモデルの採用、腫瘍学における個別化治療薬への注目の高まりに起因しています。

“2023年、モデルタイプ＆サービス別で最大のシェアを占めるモデルタイプセグメント”
2023年、世界のマウスモデル市場において、モデルタイプ＆サービス別で最大のシェアを占めたのはモデルタイプセグメントでした。マウスの遺伝子がヒトと類似していること、またマウスモデルがヒトの病気の研究、新薬や治療法の試験、生物学的プロセスの理解において重要な役割を果たしていることなどの要因が、この市場の成長を促進しています。

“アジア太平洋地域は、2024年から2029年の予測期間中、マウスモデル市場で最も高いCAGRで成長”
予測期間中、アジア太平洋地域が最も高い成長率で成長する見込みです。マウスモデルを用いた前臨床試験の採用が増加していること、ヘルスケア分野が活況を呈していることなど、さまざまな要因が同地域のマウスモデル市場の成長を後押ししています。
新規技術を開発するための製薬会社やバイオテクノロジー企業からの資金提供や投資の増加は、アジア太平洋地域におけるマウスモデル市場の成長を促進すると期待されています。同地域では生物医学研究や医薬品開発への投資が続いているため、前臨床試験や創薬活動をサポートするマウスモデルの需要が高まっています。さらに、アジア太平洋諸国における慢性疾患の有病率の増加により、疾患メカニズムの理解を深め、潜在的な治療法を検証するための信頼性の高い動物モデルの必要性が高まっています。

本レポートのために実施した主なインタビューは以下のように分類されます：
- 回答者別供給側70％、需要側30%
- 役職別 Cレベル：55％、ディレクターレベル：20％、その他：25%
- 地域別北米45％、欧州20％、アジア太平洋地域20％、中南米10％、中東3％、アフリカ2%

レポート掲載企業一覧
• Charles River Laboratories (US)
• Inotiv (US)
• THE JACKSON LABORATORY (US)
• GemPharmatech (China)
• Cyanogen (US)
• Shanghai Model Organisms Center, Inc. (China)
• JSR株式会社（日本）
• Biocytogen (China)
• 株式会社トランスジェニック（日本）
• Ozgene Pty Ltd. (Australia)
• Taconic Biosciences, Inc. (US)
• TransCure bioServices (France)
• Harbour BioMed (China)
• Marshall BioResources (US)
• genOway (France)
• Vivo Bio Tech Ltd. (India)
• ingenious targeting laboratory (US)
• Janvier Labs (France)
• Applied StemCell (US)
• Creative Animodel (US)
• JOINN Laboratories Co., Ltd. (China)
• Creative Biolabs (US)
• Crescendo Biologics (UK)
• Aragen Life Sciences (India)
• PolyGene (Switzerland)

調査範囲
本調査レポートは、マウスモデル市場市場をモデルタイプ＆サービス（モデルタイプ＆サービス）、技術（CRISPR/Cas9、マイクロインジェクション、胚性幹細胞注入、核移植、その他の技術）、治療分野（腫瘍学、神経学、代謝性疾患、免疫学、心血管疾患、エンドユーザー（製薬・バイオテクノロジー企業、学術・研究機関、CRO・CDMO）、地域別（北米、欧州、アジア太平洋、中南米、中東、アフリカ）。本レポートでは、マウスモデル市場の成長に影響を与える重要な要因（促進要因、動向、課題、機会など）について詳細な情報を提供しています。主要な産業プレイヤーを徹底的に分析し、そのビジネスプロフィール、製品/サービス、主要戦略、提携、パートナーシップ、契約に関する洞察を提供します。さらに、マウスモデル市場における新製品の発売、合併、買収などの最近の動向も網羅しています。

レポート購入の主な利点
本レポートは、マウスモデル市場全体とそのサブセグメントにおける収益数の最も近い概算値を提供することで、市場リーダーや新規参入者を支援します。また、利害関係者が競争状況をよりよく理解し、自社のビジネスをよりよく位置づけ、適切な市場参入戦略を立てるための洞察を深めるのにも役立ちます。本レポートは、関係者が市場の鼓動を理解し、主要な市場促進要因、阻害要因、機会、および課題に関する情報を提供することを可能にします。

本レポートは、以下のポイントに関する洞察を提供します：
- 市場の成長に影響を与える主要な促進要因（前臨床研究におけるマウスモデルの遺伝的・生理学的汎用性、マウス臨床試験（MCTs）の需要増加、腫瘍学における個別化医療の需要増加、遺伝子工学の進歩）、阻害要因（3Dの導入、倫理的懸念および規制上の制限）、機会（生物医学研究におけるCRISPRの活用、疾患特異的モデルの需要増加）、課題（代替動物試験法の開発、遺伝的および表現型の変動性）の分析。
- 製品開発/イノベーション：マウスモデル市場で新たに発売された製品/サービスに関する詳細な洞察
- 市場開発：有利な市場に関する包括的情報 - 本レポートでは、様々な地域の市場を分析しています。
- 市場の多様化：マウスモデル市場の新製品/サービス、未開拓地域、最近の開発、投資に関する詳細情報
- 競合他社の評価チャールズリバーラボラトリーズ（米国）、Inotiv（米国）、THE JACKSON LABORATORY（米国）、GemPharmatech（中国）、Cyagen（米国）、Shanghai Model Organisms Center, Inc.（中国）、JSR Corporation（日本）、Biocytogen（中国）、TRANS GENIC INC. （Ltd.（オーストラリア）、Taconic Biosciences, Inc.（米国）、TransCure bioServices（フランス）、Harbour BioMed（中国）、Marshall BioResources（米国）、genOway（フランス）、Vivo Bio Tech Ltd. （インド）、Ingenious Targeting Center, Inc. （インド）、ingenious targeting laboratory（米国）、Janvier Labs（フランス）、Applied StemCell（米国）、Creative Animodel（米国）、JOINN Laboratories Co. （Ltd.（中国）、Creative Biolabs（米国）、Crescendo Biologics（英国）、Aragen Life Sciences（インド）、PolyGene（スイス）など。

1 はじめに
2 調査方法
3 エグゼクティブサマリー
4 プレミアムインサイト
5 市場概要
6 マウスモデル市場：モデルタイプ＆サービス別
7 マウスモデル市場：技術別
8 マウスモデル市場：治療領域別
9 マウスモデル市場：用途別
10 マウスモデル市場：エンドユーザー別
11 マウスモデル市場：地域別
12 競争状況
13 企業プロファイル
14 付録

❖ レポートの目次 ❖

1 INTRODUCTION 51
1.1 STUDY OBJECTIVES 51
1.2 MARKET DEFINITION 51
1.2.1 INCLUSIONS & EXCLUSIONS 52
1.3 MARKET SCOPE 53
1.3.1 MARKET SEGMENTATION 53
1.3.2 REGIONS COVERED 54
1.4 YEARS CONSIDERED 54
1.5 CURRENCY CONSIDERED 55
1.6 STAKEHOLDERS 55
1.7 LIMITATIONS 55
1.8 SUMMARY OF CHANGES 56
1.9 RECESSION IMPACT 56
2 RESEARCH METHODOLOGY 57
2.1 RESEARCH DATA 57
FIGURE 1 RESEARCH DESIGN 57
2.1.1 SECONDARY DATA 58
2.1.2 PRIMARY DATA 58
FIGURE 2 MICE MODEL MARKET: BREAKDOWN OF PRIMARIES 59
2.2 MARKET ESTIMATION METHODOLOGY 59
FIGURE 3 MICE MODEL MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023 59
2.2.1 BOTTOM-UP APPROACH 60
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023 60
FIGURE 5 ILLUSTRATIVE EXAMPLE OF CHARLES RIVER LABORATORIES: REVENUE SHARE ANALYSIS (2023) 61
2.2.2 INSIGHTS FROM PRIMARY EXPERTS 62
FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES 62
2.3 TOP-DOWN APPROACH 62
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 62
2.4 GROWTH FORECAST 64
FIGURE 8 MICE MODEL MARKET: CAGR PROJECTIONS 64
2.5 MARKET BREAKDOWN AND DATA TRIANGULATION 65
FIGURE 9 DATA TRIANGULATION METHODOLOGY 65
2.6 RESEARCH ASSUMPTIONS 66
2.7 MARKET FORECAST 66
TABLE 1 FACTOR ANALYSIS 66
2.8 RISK ANALYSIS 67
2.9 RECESSION IMPACT ANALYSIS 67
3 EXECUTIVE SUMMARY 68
FIGURE 10 MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2024 VS. 2029 (USD MILLION) 68
FIGURE 11 MICE MODEL MARKET, BY TECHNOLOGY, 2024 VS. 2029 (USD MILLION) 69
FIGURE 12 MICE MODEL MARKET, BY THERAPEUTIC AREA, 2024 VS. 2029 (USD MILLION) 69
FIGURE 13 MICE MODEL MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 70
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF MICE MODEL MARKET 71
4 PREMIUM INSIGHTS 72
4.1 MICE MODEL MARKET OVERVIEW 72
FIGURE 15 RISING INVESTMENTS AND ADVANCEMENTS IN MOUSE MODEL TECHNOLOGY TO DRIVE MARKET GROWTH 72
4.2 ASIA PACIFIC: MICE MODEL MARKET, BY MODEL TYPE & SERVICE (2023) 73
FIGURE 16 MODEL TYPE SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023 73
4.3 MICE MODEL MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 74
FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 74
4.4 MICE MODEL MARKET SHARE, BY END USER 74
FIGURE 18 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE MARKET DURING FORECAST PERIOD 74
5 MARKET OVERVIEW 75
5.1 INTRODUCTION 75
5.2 MARKET DYNAMICS 75
FIGURE 19 MICE MODEL MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 75
TABLE 2 MICE MODEL MARKET: IMPACT ANALYSIS 76
5.2.1 DRIVERS 76
5.2.1.1 High adoption of mice models in preclinical studies 76
5.2.1.2 Increasing demand for mouse clinical trials (MCTs) 77
5.2.1.3 Growing preference for personalized medicine in oncology 78
5.2.1.4 Advancements in genetic engineering 78
5.2.2 RESTRAINTS 79
5.2.2.1 Introduction of 3D printed models 79
5.2.2.2 Ethical concerns and regulatory restrictions 79
5.2.3 OPPORTUNITIES 80
5.2.3.1 Utilization of CRISPR in biomedical research 80
5.2.3.2 Rising demand for disease-specific models 80
5.2.4 CHALLENGES 80
5.2.4.1 Development of alternative animal testing methods 80
5.2.4.2 Genetic & Phenotypic variability 81
5.3 MICE MODEL MARKET LANDSCAPE 81
5.3.1 HISTORY OF MICE MODELS 81
5.3.2 MICE MODEL GENERATION PROCESS 81
5.3.3 TECHNIQUES FOR MICE MODEL DEVELOPMENT 82
5.3.4 TECHNOLOGICAL ADVANCEMENTS 83
5.3.5 CONSIDERATIONS FOR MICE MODEL DEVELOPMENT 84
5.4 SUPPLY CHAIN ANALYSIS 84
FIGURE 20 MICE MODEL MARKET: SUPPLY CHAIN ANALYSIS 85
5.5 VALUE CHAIN ANALYSIS 85
FIGURE 21 MICE MODEL MARKET: VALUE CHAIN ANALYSIS 86
5.6 PRICING ANALYSIS 87
TABLE 3 AVERAGE SELLING PRICE TREND OF MODEL TYPE, BY KEY PLAYER 87
5.6.1 AVERAGE SELLING PRICE TREND ANALYSIS 87
5.7 ECOSYSTEM ANALYSIS 88
FIGURE 22 MICE MODEL MARKET: ECOSYSTEM ANALYSIS 88
5.7.1 MICE MODEL VENDORS 89
TABLE 4 MICE MODEL MARKET: ROLE IN ECOSYSTEM, BY MICE MODEL VENDORS 89
5.7.2 MICE MODEL SERVICE VENDORS 89
TABLE 5 MICE MODEL MARKET: ROLE IN ECOSYSTEM, BY SERVICE VENDOR 90
5.7.3 MICE MODEL END USERS 90
TABLE 6 MICE MODEL MARKET: ROLE IN ECOSYSTEM, BY END USER 90
5.7.4 REGULATORY ORGANIZATIONS 91
TABLE 7 MICE MODEL MARKET: ROLE IN ECOSYSTEM, BY REGULATORY ORGANIZATION 91
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 91
FIGURE 23 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 92
5.9 PATENT ANALYSIS 92
5.9.1 METHODOLOGY 92
5.9.2 PATENTS FILED, BY DOCUMENT TYPE, 2014−2024 93
TABLE 8 PATENTS FILED (2014−2024) 93
5.9.3 INNOVATION & PATENT APPLICATIONS 93
FIGURE 24 TOTAL NUMBER OF PATENTS GRANTED (2014−2024) 93
5.9.4 TOP APPLICANTS 94
FIGURE 25 TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS (2014−2024) 94
TABLE 9 TOP 20 PATENT OWNERS IN MICE MODEL MARKET (2014−2024) 94
TABLE 10 PATENTS IN MICE MODEL MARKET (2024) 95
5.10 KEY CONFERENCES & EVENTS 96
5.10.1 MICE MODEL MARKET: KEY CONFERENCES & EVENTS (2024−2025) 96
TABLE 11 MICE MODEL MARKET: CONFERENCES & EVENTS (2024−2025) 96
5.11 REGULATORY LANDSCAPE 97
5.11.1 REGULATORY ANALYSIS 97
5.11.1.1 North America 97
5.11.1.2 Europe 98
5.11.1.3 China 99
5.11.1.4 Japan 100
5.11.1.5 India 100
5.11.1.6 Australia 101
5.11.1.7 Brazil 101
5.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 101
TABLE 12 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 102
TABLE 13 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 102
TABLE 14 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 103
TABLE 15 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 104
TABLE 16 MICE MODEL MARKET: REGULATORY SCENARIO 104
5.12 PORTER’S FIVE FORCES ANALYSIS 106
TABLE 17 MICE MODEL MARKET: PORTER’S FIVE FORCES ANALYSIS 106
5.12.1 THREAT OF NEW ENTRANTS 106
5.12.2 THREAT OF SUBSTITUTES 107
5.12.3 BARGAINING POWER OF BUYERS 107
5.12.4 BARGAINING POWER OF SUPPLIERS 107
5.12.5 INTENSITY OF COMPETITIVE RIVALRY 107
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 108
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 108
FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MICE MODEL MARKET 108
TABLE 18 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR MICE MODELS & SERVICES 108
5.13.2 ROLE OF STAKEHOLDERS IN BUYING PROCESS 109
5.13.3 BUYING CRITERIA FOR MICE MODEL MARKET 109
FIGURE 27 KEY BUYING CRITERIA FOR END USERS 109
TABLE 19 BUYING CRITERIA FOR MICE MODEL TYPE & SERVICE, BY END USER 110
6 MICE MODEL MARKET, BY MODEL TYPE AND SERVICE 111
6.1 INTRODUCTION 112
TABLE 20 MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2022–2029 (USD MILLION) 112
6.2 MODEL TYPES 112
TABLE 21 MICE MODEL MARKET, BY REGION, 2022–2029 (USD MILLION) 112
TABLE 22 NORTH AMERICA: MICE MODEL TYPE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 113
TABLE 23 EUROPE: MICE MODEL TYPE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 113
TABLE 24 ASIA PACIFIC: MICE MODEL TYPE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 113
TABLE 25 LATIN AMERICA: MICE MODEL TYPE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 114
TABLE 26 MIDDLE EAST: MICE MODEL TYPE MARKET, BY REGION, 2022–2029 (USD MILLION) 114
TABLE 27 GCC COUNTRIES: MICE MODEL TYPE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 114
TABLE 28 MICE MODEL MARKET, BY TYPE, 2022–2029 (USD MILLION) 115
6.2.1 INBRED MICE 115
6.2.1.1 High utilization across research applications to propel market 115
TABLE 29 INBRED MICE MODEL MARKET, BY REGION, 2022–2029 (USD MILLION) 116
TABLE 30 NORTH AMERICA: INBRED MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 116
TABLE 31 EUROPE: INBRED MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 116
TABLE 32 ASIA PACIFIC: INBRED MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 117
TABLE 33 LATIN AMERICA: INBRED MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 117
TABLE 34 MIDDLE EAST: INBRED MICE MODEL MARKET, BY REGION, 2022–2029 (USD MILLION) 117
TABLE 35 GCC COUNTRIES: INBRED MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 118
6.2.2 GENETICALLY ENGINEERED MICE 118
6.2.2.1 Ability to induce mutations for CVD & cancer research to drive market 118
TABLE 36 GENETICALLY ENGINEERED MICE MODEL MARKET, BY REGION, 2022–2029 (USD MILLION) 119
TABLE 37 NORTH AMERICA: GENETICALLY ENGINEERED MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 119
TABLE 38 EUROPE: GENETICALLY ENGINEERED MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 119
TABLE 39 ASIA PACIFIC: GENETICALLY ENGINEERED MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 120
TABLE 40 LATIN AMERICA: GENETICALLY ENGINEERED MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 120
TABLE 41 MIDDLE EAST: GENETICALLY ENGINEERED MICE MODEL MARKET, BY REGION, 2022–2029 (USD MILLION) 120
TABLE 42 GCC COUNTRIES: GENETICALLY ENGINEERED MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 121
6.2.3 HYBRID/CONGENIC MICE 121
6.2.3.1 Growing focus on biomedical research to boost demand 121
TABLE 43 HYBRID/CONGENIC MICE MODEL MARKET, BY REGION, 2022–2029 (USD MILLION) 122
TABLE 44 NORTH AMERICA: HYBRID/CONGENIC MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 122
TABLE 45 EUROPE: HYBRID/CONGENIC MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 122
TABLE 46 ASIA PACIFIC: HYBRID/CONGENIC MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 123
TABLE 47 LATIN AMERICA: HYBRID/CONGENIC MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 123
TABLE 48 MIDDLE EAST: HYBRID/CONGENIC MICE MODEL MARKET, BY REGION, 2022–2029 (USD MILLION) 123
TABLE 49 GCC COUNTRIES: HYBRID/CONGENIC MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 124
6.2.4 OUTBRED MICE 124
6.2.4.1 Genetic diversity benefits to support market growth 124
TABLE 50 OUTBRED MICE MODEL MARKET, BY REGION, 2022–2029 (USD MILLION) 124
TABLE 51 NORTH AMERICA: OUTBRED MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 125
TABLE 52 EUROPE: OUTBRED MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 125
TABLE 53 ASIA PACIFIC: OUTBRED MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 125
TABLE 54 LATIN AMERICA: OUTBRED MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 126
TABLE 55 MIDDLE EAST: OUTBRED MICE MODEL MARKET, BY REGION, 2022–2029 (USD MILLION) 126
TABLE 56 GCC COUNTRIES: OUTBRED MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 126
6.3 SERVICES 127
TABLE 57 MICE MODEL SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 127
TABLE 58 NORTH AMERICA: MICE MODEL SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 127
TABLE 59 EUROPE: MICE MODEL SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 128
TABLE 60 ASIA PACIFIC: MICE MODEL SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 128
TABLE 61 LATIN AMERICA: MICE MODEL SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 128
TABLE 62 MIDDLE EAST: MICE MODEL SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 129
TABLE 63 GCC COUNTRIES: MICE MODEL SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 129
TABLE 64 MICE MODEL SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 129
6.3.1 BREEDING SERVICES 130
6.3.1.1 Customization of models for specific research applications to boost demand 130
TABLE 65 MICE MODEL BREEDING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 130
TABLE 66 NORTH AMERICA: MICE MODEL BREEDING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 131
TABLE 67 EUROPE: MICE MODEL BREEDING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 131
TABLE 68 ASIA PACIFIC: MICE MODEL BREEDING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 131
TABLE 69 LATIN AMERICA: MICE MODEL BREEDING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 132
TABLE 70 MIDDLE EAST: MICE MODEL BREEDING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 132
TABLE 71 GCC COUNTRIES: MICE MODEL BREEDING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 132
6.3.2 CRYOPRESERVATION SERVICES 133
6.3.2.1 Rising focus on preservation of novel mice models to propel market 133
TABLE 72 MICE MODEL CRYOPRESERVATION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 133
TABLE 73 NORTH AMERICA: MICE MODEL CRYOPRESERVATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 134
TABLE 74 EUROPE: MICE MODEL CRYOPRESERVATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 134
TABLE 75 ASIA PACIFIC: MICE MODEL CRYOPRESERVATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 135
TABLE 76 LATIN AMERICA: MICE MODEL CRYOPRESERVATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 135
TABLE 77 MIDDLE EAST: MICE MODEL CRYOPRESERVATION SERVICES MARKET, BY REGION 2022–2029 (USD MILLION) 135
TABLE 78 GCC COUNTRIES: MICE MODEL CRYOPRESERVATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 136
6.3.3 REDERIVATION SERVICES 136
6.3.3.1 Stringent quality assurance standards to fuel market 136
TABLE 79 MICE MODEL REDERIVATION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 136
TABLE 80 NORTH AMERICA: MICE MODEL REDERIVATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 137
TABLE 81 EUROPE: MICE MODEL REDERIVATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 137
TABLE 82 ASIA PACIFIC: MICE MODEL REDERIVATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 138
TABLE 83 LATIN AMERICA: MICE MODEL REDERIVATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 138
TABLE 84 MIDDLE EAST: MICE MODEL REDERIVATION SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 138
TABLE 85 GCC COUNTRIES: MICE MODEL REDERIVATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 139
6.3.4 QUARANTINE SERVICES 139
6.3.4.1 Rising demand for germ-free mice to support market growth 139
TABLE 86 MICE MODEL QUARANTINE SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 140
TABLE 87 NORTH AMERICA: MICE MODEL QUARANTINE SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 140
TABLE 88 EUROPE: MICE MODEL QUARANTINE SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 141
TABLE 89 ASIA PACIFIC: MICE MODEL QUARANTINE SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 141
TABLE 90 LATIN AMERICA: MICE MODEL QUARANTINE SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 142
TABLE 91 MIDDLE EAST: MICE MODEL QUARANTINE SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 142
TABLE 92 GCC COUNTRIES: MICE MODEL QUARANTINE SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 142
6.3.5 OTHER SERVICES 143
TABLE 93 MICE MODEL OTHER SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 143
TABLE 94 NORTH AMERICA: MICE MODEL OTHER SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 144
TABLE 95 EUROPE: MICE MODEL OTHER SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 144
TABLE 96 ASIA PACIFIC: MICE MODEL OTHER SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 145
TABLE 97 LATIN AMERICA: MICE MODEL OTHER SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 145
TABLE 98 MIDDLE EAST: MICE MODEL OTHER SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 145
TABLE 99 GCC COUNTRIES: MICE MODEL OTHER SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 146
7 MICE MODEL MARKET, BY TECHNOLOGY 147
7.1 INTRODUCTION 148
TABLE 100 MICE MODEL MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 148
7.2 CRISPR/CAS9 148
7.2.1 ADVANTAGES SUCH AS SIMPLIFIED DESIGN AND COST EFFICIENCY TO BOOST DEMAND 148
TABLE 101 CRISPR/CAS9 MARKET, BY REGION, 2022–2029 (USD MILLION) 149
TABLE 102 NORTH AMERICA: CRISPR/CAS9 MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 149
TABLE 103 EUROPE: CRISPR/CAS9 MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 149
TABLE 104 ASIA PACIFIC: CRISPR/CAS9 MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 150
TABLE 105 LATIN AMERICA: CRISPR/CAS9 MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 150
TABLE 106 MIDDLE EAST: CRISPR/CAS9 MARKET, BY REGION, 2022–2029 (USD MILLION) 150
TABLE 107 GCC COUNTRIES: CRISPR/CAS9 MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 151
7.3 MICROINJECTION 151
7.3.1 LOW TOXICITY AND HIGH SUCCESS RATE TO PROPEL MARKET 151
TABLE 108 MICROINJECTION MARKET, BY REGION, 2022–2029 (USD MILLION) 152
TABLE 109 NORTH AMERICA: MICROINJECTION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 152
TABLE 110 EUROPE: MICROINJECTION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 152
TABLE 111 ASIA PACIFIC: MICROINJECTION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 153
TABLE 112 LATIN AMERICA: MICROINJECTION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 153
TABLE 113 MIDDLE EAST: MICROINJECTION MARKET, BY REGION, 2022–2029 (USD MILLION) 153
TABLE 114 GCC COUNTRIES: MICROINJECTION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 154
7.4 EMBRYONIC STEM CELL INJECTION 154
7.4.1 RISING DEMAND FOR TARGETED MICE MODELS IN IMMUNOLOGICAL RESEARCH TO DRIVE MARKET 154
TABLE 115 EMBRYONIC STEM CELL INJECTION MARKET, BY REGION, 2022–2029 (USD MILLION) 155
TABLE 116 NORTH AMERICA: EMBRYONIC STEM CELL INJECTION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 155
TABLE 117 EUROPE: EMBRYONIC STEM CELL INJECTION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 155
TABLE 118 ASIA PACIFIC: EMBRYONIC STEM CELL INJECTION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 156
TABLE 119 LATIN AMERICA: EMBRYONIC STEM CELL INJECTION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 156
TABLE 120 MIDDLE EAST: EMBRYONIC STEM CELL INJECTION MARKET, BY REGION, 2022–2029 (USD MILLION) 156
TABLE 121 GCC COUNTRIES: EMBRYONIC STEM CELL INJECTION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 157
7.5 NUCLEAR TRANSFER 157
7.5.1 POTENTIAL TO PRODUCE IDENTICAL MICE TO DRIVE MARKET 157
TABLE 122 NUCLEAR TRANSFER MARKET, BY REGION, 2022–2029 (USD MILLION) 158
TABLE 123 NORTH AMERICA: NUCLEAR TRANSFER MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 158
TABLE 124 EUROPE: NUCLEAR TRANSFER MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 158
TABLE 125 ASIA PACIFIC: NUCLEAR TRANSFER MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 159
TABLE 126 LATIN AMERICA: NUCLEAR TRANSFER MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 159
TABLE 127 MIDDLE EAST: NUCLEAR TRANSFER MARKET, BY REGION, 2022–2029 (USD MILLION) 159
TABLE 128 GCC COUNTRIES: NUCLEAR TRANSFER MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 160
7.6 OTHER TECHNOLOGIES 160
TABLE 129 OTHER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION) 161
TABLE 130 NORTH AMERICA: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 161
TABLE 131 EUROPE: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 161
TABLE 132 ASIA PACIFIC: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 162
TABLE 133 LATIN AMERICA: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 162
TABLE 134 MIDDLE EAST: OTHER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION) 162
TABLE 135 GCC COUNTRIES: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 163
8 MICE MODEL MARKET, BY THERAPEUTIC AREA 164
8.1 INTRODUCTION 165
TABLE 136 MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION) 165
8.2 ONCOLOGY 165
8.2.1 GROWING FOCUS ON ONCOLOGY THERAPEUTIC DEVELOPMENT TO PROPEL MARKET 165
TABLE 137 MICE MODEL MARKET FOR ONCOLOGY, BY REGION, 2022–2029 (USD MILLION) 166
TABLE 138 NORTH AMERICA: MICE MODEL MARKET FOR ONCOLOGY, BY COUNTRY, 2022–2029 (USD MILLION) 166
TABLE 139 EUROPE: MICE MODEL MARKET FOR ONCOLOGY, BY COUNTRY, 2022–2029 (USD MILLION) 167
TABLE 140 ASIA PACIFIC: MICE MODEL MARKET FOR ONCOLOGY, BY COUNTRY, 2022–2029 (USD MILLION) 167
TABLE 141 LATIN AMERICA: MICE MODEL MARKET FOR ONCOLOGY, BY COUNTRY, 2022–2029 (USD MILLION) 168
TABLE 142 MIDDLE EAST: MICE MODEL MARKET FOR ONCOLOGY, BY REGION, 2022–2029 (USD MILLION) 168
TABLE 143 GCC COUNTRIES: MICE MODEL MARKET FOR ONCOLOGY, BY COUNTRY, 2022–2029 (USD MILLION) 168
8.3 METABOLIC DISEASES 169
8.3.1 RISING PREVALENCE OF DIABETES TO DRIVE MARKET 169
TABLE 144 MICE MODEL MARKET FOR METABOLIC DISEASES, BY REGION, 2022–2029 (USD MILLION) 169
TABLE 145 NORTH AMERICA: MICE MODEL MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2022–2029 (USD MILLION) 170
TABLE 146 EUROPE: MICE MODEL MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2022–2029 (USD MILLION) 170
TABLE 147 ASIA PACIFIC: MICE MODEL MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2022–2029 (USD MILLION) 171
TABLE 148 LATIN AMERICA: MICE MODEL MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2022–2029 (USD MILLION) 171
TABLE 149 MIDDLE EAST: MICE MODEL MARKET FOR METABOLIC DISEASES, BY REGION, 2022–2029 (USD MILLION) 171
TABLE 150 GCC COUNTRIES: MICE MODEL MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2022–2029 (USD MILLION) 172
8.4 IMMUNOLOGY 172
8.4.1 INCREASING CLINICAL RESEARCH FOR IMMUNOLOGICAL DISORDERS TO FUEL MARKET 172
TABLE 151 MICE MODEL MARKET FOR IMMUNOLOGY, BY REGION, 2022–2029 (USD MILLION) 173
TABLE 152 NORTH AMERICA: MICE MODEL MARKET FOR IMMUNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION) 173
TABLE 153 EUROPE: MICE MODEL MARKET FOR IMMUNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION) 173
TABLE 154 ASIA PACIFIC: MICE MODEL MARKET FOR IMMUNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION) 174
TABLE 155 LATIN AMERICA: MICE MODEL MARKET FOR IMMUNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION) 174
TABLE 156 MIDDLE EAST: MICE MODEL MARKET FOR IMMUNOLOGY, BY REGION, 2022–2029 (USD MILLION) 174
TABLE 157 GCC COUNTRIES: MICE MODEL MARKET FOR IMMUNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION) 175
8.5 NEUROLOGY 175
8.5.1 INCREASING INVESTMENTS IN R&D FOR CNS DISEASES TO SUPPORT MARKET GROWTH 175
TABLE 158 MICE MODEL MARKET FOR NEUROLOGY, BY REGION, 2022–2029 (USD MILLION) 176
TABLE 159 NORTH AMERICA: MICE MODEL MARKET FOR NEUROLOGY, BY COUNTRY, 2022–2029 (USD MILLION) 176
TABLE 160 EUROPE: MICE MODEL MARKET FOR NEUROLOGY, BY COUNTRY, 2022–2029 (USD MILLION) 176
TABLE 161 ASIA PACIFIC: MICE MODEL MARKET FOR NEUROLOGY, BY COUNTRY, 2022–2029 (USD MILLION) 177
TABLE 162 LATIN AMERICA: MICE MODEL MARKET FOR NEUROLOGY, BY COUNTRY, 2022–2029 (USD MILLION) 177
TABLE 163 MIDDLE EAST: MICE MODEL MARKET FOR NEUROLOGY, BY REGION, 2022–2029 (USD MILLION) 177
TABLE 164 GCC COUNTRIES: MICE MODEL MARKET FOR NEUROLOGY, BY COUNTRY, 2022–2029 (USD MILLION) 178
8.6 CARDIOVASCULAR DISEASES 178
8.6.1 GROWING FOCUS ON TARGETED TREATMENTS FOR CVD TO BOOST DEMAND 178
TABLE 165 MICE MODEL MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2022–2029 (USD MILLION) 179
TABLE 166 NORTH AMERICA: MICE MODEL MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2022–2029 (USD MILLION) 179
TABLE 167 EUROPE: MICE MODEL MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2022–2029 (USD MILLION) 179
TABLE 168 ASIA PACIFIC: MICE MODEL MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2022–2029 (USD MILLION) 180
TABLE 169 LATIN AMERICA: MICE MODEL MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2022–2029 (USD MILLION) 180
TABLE 170 MIDDLE EAST: MICE MODEL MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2022–2029 (USD MILLION) 180
TABLE 171 GCC COUNTRIES: MICE MODEL MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2022–2029 (USD MILLION) 181
8.7 OTHER THERAPEUTIC AREAS 181
TABLE 172 MICE MODEL MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2022–2029 (USD MILLION) 182
TABLE 173 NORTH AMERICA: MICE MODEL MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2022–2029 (USD MILLION) 182
TABLE 174 EUROPE: MICE MODEL MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2022–2029 (USD MILLION) 182
TABLE 175 ASIA PACIFIC: MICE MODEL MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2022–2029 (USD MILLION) 183
TABLE 176 LATIN AMERICA: MICE MODEL MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2022–2029 (USD MILLION) 183
TABLE 177 MIDDLE EAST: MICE MODEL MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2022–2029 (USD MILLION) 183
TABLE 178 GCC COUNTRIES: MICE MODEL MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2022–2029 (USD MILLION) 184
9 MICE MODEL MARKET, BY APPLICATION 185
9.1 INTRODUCTION 186
TABLE 179 MICE MODEL MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 186
9.2 DRUG DISCOVERY & DEVELOPMENT 186
9.2.1 RISING NUMBER OF CLINICAL TRIALS TO DRIVE MARKET 186
TABLE 180 MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2022–2029 (USD MILLION) 187
TABLE 181 NORTH AMERICA: MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION) 187
TABLE 182 EUROPE: MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION) 187
TABLE 183 ASIA PACIFIC: MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION) 188
TABLE 184 LATIN AMERICA: MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION) 188
TABLE 185 MIDDLE EAST: MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION) 188
TABLE 186 GCC COUNTRIES: MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION) 189
9.3 RESEARCH APPLICATIONS 189
9.3.1 RISING FUNDING FOR CANCER RESEARCH TO BOOST DEMAND 189
TABLE 187 MICE MODEL MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 190
TABLE 188 NORTH AMERICA: MICE MODEL MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 190
TABLE 189 EUROPE: MICE MODEL MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 190
TABLE 190 ASIA PACIFIC: MICE MODEL MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 191
TABLE 191 LATIN AMERICA: MICE MODEL MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 191
TABLE 192 MIDDLE EAST: MICE MODEL MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 191
TABLE 193 GCC COUNTRIES: MICE MODEL MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 192
9.4 PERSONALIZED MEDICINE 192
9.4.1 GROWING PREFERENCE FOR ONCOLOGY THERAPEUTICS TO PROPEL MARKET 192
TABLE 194 MICE MODEL MARKET FOR PERSONALIZED MEDICINE, BY REGION, 2022–2029 (USD MILLION) 193
TABLE 195 NORTH AMERICA: MICE MODEL MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION) 193
TABLE 196 EUROPE: MICE MODEL MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION) 193
TABLE 197 ASIA PACIFIC: MICE MODEL MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION) 194
TABLE 198 LATIN AMERICA: MICE MODEL MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION) 194
TABLE 199 MIDDLE EAST: MICE MODEL MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION) 194
TABLE 200 GCC COUNTRIES: MICE MODEL MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION) 195
10 MICE MODEL MARKET, BY END USER 196
10.1 INTRODUCTION 197
TABLE 201 MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION) 197
10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 197
10.2.1 RISING EXPENDITURE ON R&D FOR DRUG DEVELOPMENT TO BOOST DEMAND 197
TABLE 202 MICE MODEL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION) 198
TABLE 203 NORTH AMERICA: MICE MODEL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 198
TABLE 204 EUROPE: MICE MODEL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 199
TABLE 205 ASIA PACIFIC: MICE MODEL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 199
TABLE 206 LATIN AMERICA: MICE MODEL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 200
TABLE 207 MIDDLE EAST: MICE MODEL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION) 200
TABLE 208 GCC COUNTRIES: MICE MODEL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 200
10.3 ACADEMIC & RESEARCH INSTITUTES 201
10.3.1 INCREASING FUNDING INITIATIVES FOR LIFE SCIENCES R&D TO SUPPORT MARKET GROWTH 201
TABLE 209 MICE MODEL MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION) 201
TABLE 210 NORTH AMERICA: MICE MODEL MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 202
TABLE 211 EUROPE: MICE MODEL MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 202
TABLE 212 ASIA PACIFIC: MICE MODEL MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 202
TABLE 213 LATIN AMERICA: MICE MODEL MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 203
TABLE 214 MIDDLE EAST: MICE MODEL MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION) 203
TABLE 215 GCC COUNTRIES: MICE MODEL MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 203
10.4 CONTRACT RESEARCH ORGANIZATIONS AND CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS 204
10.4.1 RISING OUTSOURCING OF DRUG DISCOVERY SERVICES TO PROPEL MARKET 204
TABLE 216 MICE MODEL MARKET FOR CROS & CDMOS, BY REGION, 2022–2029 (USD MILLION) 204
TABLE 217 NORTH AMERICA: MICE MODEL MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION) 205
TABLE 218 EUROPE: MICE MODEL MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION) 205
TABLE 219 ASIA PACIFIC: MICE MODEL MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION) 205
TABLE 220 LATIN AMERICA: MICE MODEL MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 USD MILLION) 206
TABLE 221 MIDDLE EAST: MICE MODEL MARKET FOR CROS & CDMOS, BY REGION, 2022–2029 (USD MILLION) 206
TABLE 222 GCC COUNTRIES: MICE MODEL MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION) 206
11 MICE MODEL MARKET, BY REGION 207
11.1 INTRODUCTION 208
TABLE 223 MICE MODEL MARKET, BY REGION, 2022–2029 (USD MILLION) 208
11.2 NORTH AMERICA 208
11.2.1 NORTH AMERICA: RECESSION IMPACT 208
FIGURE 28 NORTH AMERICA: MICE MODEL MARKET SNAPSHOT 209
TABLE 224 NORTH AMERICA: MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 210
TABLE 225 NORTH AMERICA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION) 210
TABLE 226 NORTH AMERICA: MICE MODEL MARKET, BY TYPE, 2022–2029 (USD MILLION) 210
TABLE 227 NORTH AMERICA: MICE MODEL MARKET, BY SERVICE, 2022–2029 (USD MILLION) 211
TABLE 228 NORTH AMERICA: MICE MODEL MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 211
TABLE 229 NORTH AMERICA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION) 212
TABLE 230 NORTH AMERICA: MICE MODEL MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 212
TABLE 231 NORTH AMERICA: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION 212
11.2.2 US 213
11.2.2.1 Rising production of monoclonal antibodies to fuel market for mice models 213
TABLE 232 US: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION) 214
TABLE 233 US: MICE MODEL MARKET, BY TYPE, 2022–2029 (USD MILLION) 214
TABLE 234 US: MICE MODEL MARKET, BY SERVICE, 2022–2029 (USD MILLION) 214
TABLE 235 US: MICE MODEL MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 215
TABLE 236 US: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION) 215
TABLE 237 US: MICE MODEL MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 215
TABLE 238 US: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION 216
11.2.3 CANADA 216
11.2.3.1 Growth in stem cell research activities to support market growth 216
TABLE 239 CANADA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION) 216
TABLE 240 CANADA: MICE MODEL MARKET, BY TYPE, 2022–2029 (USD MILLION) 217
TABLE 241 CANADA: MICE MODEL MARKET, BY SERVICE, 2022–2029 (USD MILLION) 217
TABLE 242 CANADA: MICE MODEL MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 217
TABLE 243 CANADA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION) 218
TABLE 244 CANADA: MICE MODEL MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 218
TABLE 245 CANADA: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION 218

11.3 EUROPE 219
11.3.1 EUROPE: RECESSION IMPACT 219
TABLE 246 EUROPE: MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 219
TABLE 247 EUROPE: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION) 220
TABLE 248 EUROPE: MICE MODEL MARKET, BY TYPE, 2022–2029 (USD MILLION) 220
TABLE 249 EUROPE: MICE MODEL MARKET, BY SERVICE, 2022–2029 (USD MILLION) 220
TABLE 250 EUROPE: MICE MODEL MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 221
TABLE 251 EUROPE: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION) 221
TABLE 252 EUROPE: MICE MODEL MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 221
TABLE 253 EUROPE: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION) 222
11.3.2 GERMANY 222
11.3.2.1 Growing biotechnology industry to drive market 222
TABLE 254 GERMANY: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION) 223
TABLE 255 GERMANY: MICE MODEL MARKET, BY TYPE, 2022–2029 (USD MILLION) 223
TABLE 256 GERMANY: MICE MODEL MARKET, BY SERVICE, 2022–2029 (USD MILLION) 223
TABLE 257 GERMANY: MICE MODEL MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 224
TABLE 258 GERMANY: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION) 224
TABLE 259 GERMANY: MICE MODEL MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 224
TABLE 260 GERMANY: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION) 225
11.3.3 UK 225
11.3.3.1 Increasing focus on cancer research to propel market 225
TABLE 261 UK: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION) 225
TABLE 262 UK: MICE MODEL MARKET, BY TYPE, 2022–2029 (USD MILLION) 226
TABLE 263 UK: MICE MODEL MARKET, BY SERVICE, 2022–2029 (USD MILLION) 226
TABLE 264 UK: MICE MODEL MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 226
TABLE 265 UK: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION) 227
TABLE 266 UK: MICE MODEL MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 227
TABLE 267 UK: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION) 227
11.3.4 FRANCE 228
11.3.4.1 Increased investments in proteomics and genomics to fuel growth 228
TABLE 268 FRANCE: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION) 228
TABLE 269 FRANCE: MICE MODEL MARKET, BY TYPE, 2022–2029 (USD MILLION) 228
TABLE 270 FRANCE: MICE MODEL MARKET, BY SERVICE, 2022–2029 (USD MILLION) 229
TABLE 271 FRANCE: MICE MODEL MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 229
TABLE 272 FRANCE: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION) 229
TABLE 273 FRANCE: MICE MODEL MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 230
TABLE 274 FRANCE: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION) 230
11.3.5 ITALY 230
11.3.5.1 Growth in pharmaceutical and biotechnology industry to drive market 230
TABLE 275 ITALY: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION) 231
TABLE 276 ITALY: MICE MODEL MARKET, BY TYPE, 2022–2029 (USD MILLION) 231
TABLE 277 ITALY: MICE MODEL MARKET, BY SERVICE, 2022–2029 (USD MILLION) 231
TABLE 278 ITALY: MICE MODEL MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 232
TABLE 279 ITALY: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION) 232
TABLE 280 ITALY: MICE MODEL MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 232
TABLE 281 ITALY: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION) 233
11.3.6 SPAIN 233
11.3.6.1 Extensive R&D pipeline to support market growth 233
TABLE 282 SPAIN: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION) 234
TABLE 283 SPAIN: MICE MODEL MARKET, BY TYPE, 2022–2029 (USD MILLION) 234
TABLE 284 SPAIN: MICE MODEL MARKET, BY SERVICE, 2022–2029 (USD MILLION) 234
TABLE 285 SPAIN: MICE MODEL MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 235
TABLE 286 SPAIN: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION) 235
TABLE 287 SPAIN: MICE MODEL MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 235
TABLE 288 SPAIN: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION) 236
11.3.7 REST OF EUROPE 236
TABLE 289 REST OF EUROPE: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION) 237
TABLE 290 REST OF EUROPE: MICE MODEL MARKET, BY TYPE, 2022–2029 (USD MILLION) 237
TABLE 291 REST OF EUROPE: MICE MODEL MARKET, BY SERVICE, 2022–2029 (USD MILLION) 237
TABLE 292 REST OF EUROPE: MICE MODEL MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 238
TABLE 293 REST OF EUROPE: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION) 238
TABLE 294 REST OF EUROPE: MICE MODEL MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 238
TABLE 295 REST OF EUROPE: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION) 239
11.4 ASIA PACIFIC 239
11.4.1 ASIA PACIFIC: RECESSION IMPACT 239
FIGURE 29 ASIA PACIFIC: MICE MODEL MARKET SNAPSHOT 240
TABLE 296 ASIA PACIFIC: MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 241
TABLE 297 ASIA PACIFIC: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION) 241
TABLE 298 ASIA PACIFIC: MICE MODEL MARKET, BY TYPE, 2022–2029 (USD MILLION) 241
TABLE 299 ASIA PACIFIC: MICE MODEL MARKET, BY SERVICE, 2022–2029 (USD MILLION) 242
TABLE 300 ASIA PACIFIC: MICE MODEL MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 242
TABLE 301 ASIA PACIFIC: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION) 242
TABLE 302 ASIA PACIFIC: MICE MODEL MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 243
TABLE 303 ASIA PACIFIC: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION) 243
11.4.2 CHINA 243
11.4.2.1 Growing funding and investments in life sciences research to drive market 243
TABLE 304 CHINA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION) 244
TABLE 305 CHINA: MICE MODEL MARKET, BY TYPE, 2022–2029 (USD MILLION) 244
TABLE 306 CHINA: MICE MODEL MARKET, BY SERVICE, 2022–2029 (USD MILLION) 244
TABLE 307 CHINA: MICE MODEL MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 245
TABLE 308 CHINA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION) 245
TABLE 309 CHINA: MICE MODEL MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 245
TABLE 310 CHINA: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION) 246
11.4.3 JAPAN 246
11.4.3.1 Increasing focus on personalized diagnostics products to drive market 246
TABLE 311 JAPAN: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION) 246
TABLE 312 JAPAN: MICE MODEL MARKET, BY TYPE, 2022–2029 (USD MILLION) 247
TABLE 313 JAPAN: MICE MODEL MARKET, BY SERVICE, 2022–2029 (USD MILLION) 247
TABLE 314 JAPAN: MICE MODEL MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 247
TABLE 315 JAPAN: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION) 248
TABLE 316 JAPAN: MICE MODEL MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 248
TABLE 317 JAPAN: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION) 248
11.4.4 INDIA 249
11.4.4.1 Increasing initiatives for drug discovery to boost market growth 249
TABLE 318 INDIA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION) 249
TABLE 319 INDIA: MICE MODEL MARKET, BY TYPE, 2022–2029 (USD MILLION) 249
TABLE 320 INDIA: MICE MODEL MARKET, BY SERVICE, 2022–2029 (USD MILLION) 250
TABLE 321 INDIA: MICE MODEL MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 250
TABLE 322 INDIA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION) 250
TABLE 323 INDIA: MICE MODEL MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 251
TABLE 324 INDIA: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION) 251
11.4.5 AUSTRALIA 251
11.4.5.1 High number of research institutes to favor market growth 251
TABLE 325 AUSTRALIA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION) 252
TABLE 326 AUSTRALIA: MICE MODEL MARKET, BY TYPE, 2022–2029 (USD MILLION) 252
TABLE 327 AUSTRALIA: MICE MODEL MARKET, BY SERVICE, 2022–2029 (USD MILLION) 252
TABLE 328 AUSTRALIA: MICE MODEL MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 253
TABLE 329 AUSTRALIA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION) 253
TABLE 330 AUSTRALIA: MICE MODEL MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 253
TABLE 331 AUSTRALIA: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION) 254
11.4.6 SOUTH KOREA 254
11.4.6.1 Rising R&D investments in drug development to fuel uptake of genetically engineered mice models 254
TABLE 332 SOUTH KOREA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION) 255
TABLE 333 SOUTH KOREA: MICE MODEL MARKET, BY TYPE, 2022–2029 (USD MILLION) 255
TABLE 334 SOUTH KOREA: MICE MODEL MARKET, BY SERVICE, 2022–2029 (USD MILLION) 255
TABLE 335 SOUTH KOREA: MICE MODEL MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 256
TABLE 336 SOUTH KOREA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION) 256
TABLE 337 SOUTH KOREA: MICE MODEL MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 256
TABLE 338 SOUTH KOREA: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION) 257
11.4.7 REST OF ASIA PACIFIC 257
TABLE 339 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION) 258
TABLE 340 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY TYPE, 2022–2029 (USD MILLION) 258
TABLE 341 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY SERVICE, 2022–2029 (USD MILLION) 258
TABLE 342 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 259
TABLE 343 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION) 259
TABLE 344 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 260
TABLE 345 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION) 260
11.5 LATIN AMERICA 260
11.5.1 LATIN AMERICA: RECESSION IMPACT 260
TABLE 346 LATIN AMERICA: MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 261
TABLE 347 LATIN AMERICA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION) 261
TABLE 348 LATIN AMERICA: MICE MODEL MARKET, BY TYPE, 2022–2029 (USD MILLION) 262
TABLE 349 LATIN AMERICA: MICE MODEL MARKET, BY SERVICE, 2022–2029 (USD MILLION) 262
TABLE 350 LATIN AMERICA: MICE MODEL MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 262
TABLE 351 LATIN AMERICA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION) 263
TABLE 352 LATIN AMERICA: MICE MODEL MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 263
TABLE 353 LATIN AMERICA: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION 263
11.5.2 BRAZIL 264
11.5.2.1 Increasing Investments in Biopharmaceutical research to propel market growth 264
TABLE 354 BRAZIL: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION) 264
TABLE 355 BRAZIL: MICE MODEL MARKET, BY TYPE, 2022–2029 (USD MILLION) 264
TABLE 356 BRAZIL: MICE MODEL MARKET, BY SERVICE, 2022–2029 (USD MILLION) 265
TABLE 357 BRAZIL: MICE MODEL MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 265
TABLE 358 BRAZIL: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION) 265
TABLE 359 BRAZIL: MICE MODEL MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 266
TABLE 360 BRAZIL: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION 266
11.5.3 MEXICO 266
11.5.3.1 Expanding healthcare ecosystem to support market growth 266
TABLE 361 MEXICO: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION) 267
TABLE 362 MEXICO: MICE MODEL MARKET, BY TYPE, 2022–2029 (USD MILLION) 267
TABLE 363 MEXICO: MICE MODEL MARKET, BY SERVICE, 2022–2029 (USD MILLION) 267
TABLE 364 MEXICO: MICE MODEL MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 268
TABLE 365 MEXICO: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION) 268
TABLE 366 MEXICO: MICE MODEL MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 268
TABLE 367 MEXICO: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION 269
11.5.4 REST OF LATIN AMERICA 269
TABLE 368 REST OF LATIN AMERICA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION) 270
TABLE 369 REST OF LATIN AMERICA: MICE MODEL MARKET, BY TYPE, 2022–2029 (USD MILLION) 270
TABLE 370 REST OF LATIN AMERICA: MICE MODEL MARKET, BY SERVICE, 2022–2029 (USD MILLION) 270
TABLE 371 REST OF LATIN AMERICA: MICE MODEL MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 271
TABLE 372 REST OF LATIN AMERICA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION) 271
TABLE 373 REST OF LATIN AMERICA: MICE MODEL MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 271
TABLE 374 REST OF LATIN AMERICA: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION 272
11.6 MIDDLE EAST 272
11.6.1 MIDDLE EAST: RECESSION IMPACT 272
TABLE 375 MIDDLE EAST: MICE MODEL MARKET, BY REGION, 2022–2029 (USD MILLION) 273
TABLE 376 MIDDLE EAST: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION) 273
TABLE 377 MIDDLE EAST: MICE MODEL MARKET, BY TYPE, 2022–2029 (USD MILLION) 273
TABLE 378 MIDDLE EAST: MICE MODEL MARKET, BY SERVICE, 2022–2029 (USD MILLION) 274
TABLE 379 MIDDLE EAST: MICE MODEL MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 274
TABLE 380 MIDDLE EAST: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION) 275
TABLE 381 MIDDLE EAST: MICE MODEL MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 275
TABLE 382 MIDDLE EAST: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION 275
11.6.2 GCC COUNTRIES 276
TABLE 383 GCC COUNTRIES: MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 276
TABLE 384 GCC COUNTRIES: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION) 276
TABLE 385 GCC COUNTRIES: MICE MODEL MARKET, BY TYPE, 2022–2029 (USD MILLION) 277
TABLE 386 GCC COUNTRIES: MICE MODEL MARKET, BY SERVICE, 2022–2029 (USD MILLION) 277
TABLE 387 GCC COUNTRIES: MICE MODEL MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 277
TABLE 388 GCC COUNTRIES: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION) 278
TABLE 389 GCC COUNTRIES: MICE MODEL MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 278
TABLE 390 GCC COUNTRIES: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION 278
11.6.2.1 SAUDI ARABIA 279
11.6.2.1.1 Growing focus on advancement of healthcare sector to boost market growth 279
TABLE 391 SAUDI ARABIA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION) 279
TABLE 392 SAUDI ARABIA: MICE MODEL MARKET, BY TYPE, 2022–2029 (USD MILLION) 280
TABLE 393 SAUDI ARABIA: MICE MODEL MARKET, BY SERVICE, 2022–2029 (USD MILLION) 280
TABLE 394 SAUDI ARABIA: MICE MODEL MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 280
TABLE 395 SAUDI ARABIA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION) 281
TABLE 396 SAUDI ARABIA: MICE MODEL MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 281
TABLE 397 SAUDI ARABIA: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION) 281
11.6.2.2 UNITED ARAB EMIRATES 282
11.6.2.2.1 Increasing R&D activities and growing demand for personalized medicine to propel market 282
TABLE 398 UNITED ARAB EMIRATES: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION) 282
TABLE 399 UNITED ARAB EMIRATES: MICE MODEL MARKET, BY TYPE, 2022–2029 (USD MILLION) 282
TABLE 400 UNITED ARAB EMIRATES: MICE MODEL MARKET, BY SERVICE, 2022–2029 (USD MILLION) 283
TABLE 401 UNITED ARAB EMIRATES: MICE MODEL MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 283
TABLE 402 UNITED ARAB EMIRATES: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION) 284
TABLE 403 UNITED ARAB EMIRATES: MICE MODEL MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 284
TABLE 404 UNITED ARAB EMIRATES: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION 284
11.6.2.3 REST OF GCC COUNTRIES 285
TABLE 405 REST OF GCC COUNTRIES: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION) 285
TABLE 406 REST OF GCC COUNTRIES: MICE MODEL MARKET, BY TYPE, 2022–2029 (USD MILLION) 286
TABLE 407 REST OF GCC COUNTRIES: MICE MODEL MARKET, BY SERVICE, 2022–2029 (USD MILLION) 286
TABLE 408 REST OF GCC COUNTRIES: MICE MODEL MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 286
TABLE 409 REST OF GCC COUNTRIES: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION) 287
TABLE 410 REST OF GCC COUNTRIES: MICE MODEL MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 287
TABLE 411 REST OF GCC COUNTRIES: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION 287
11.6.3 REST OF MIDDLE EAST 288
TABLE 412 REST OF MIDDLE EAST: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION) 288
TABLE 413 REST OF MIDDLE EAST: MICE MODEL MARKET, BY TYPE, 2022–2029 (USD MILLION) 289
TABLE 414 REST OF MIDDLE EAST: MICE MODEL MARKET, BY SERVICE, 2022–2029 (USD MILLION) 289
TABLE 415 REST OF MIDDLE EAST: MICE MODEL MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 289
TABLE 416 REST OF MIDDLE EAST: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION) 290
TABLE 417 REST OF MIDDLE EAST: MICE MODEL MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 290
TABLE 418 REST OF MIDDLE EAST: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION 290
11.7 AFRICA 291
11.7.1 GROWING PRECISION MEDICINE INITIATIVES TO FUEL MARKET GROWTH 291
11.7.2 AFRICA: RECESSION IMPACT 291
TABLE 419 AFRICA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION) 291
TABLE 420 AFRICA: MICE MODEL MARKET, BY TYPE, 2022–2029 (USD MILLION) 292
TABLE 421 AFRICA: MICE MODEL MARKET, BY SERVICE, 2022–2029 (USD MILLION) 292
TABLE 422 AFRICA: MICE MODEL MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 292
TABLE 423 AFRICA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION) 293
TABLE 424 AFRICA: MICE MODEL MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 293
TABLE 425 AFRICA: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION 293
12 COMPETITIVE LANDSCAPE 294
12.1 OVERVIEW 294
12.2 KEY PLAYERS STRATEGIES/RIGHT TO WIN 294
TABLE 426 KEY PLAYERS STRATEGIES IN MICE MODEL MARKET, 2021−2024 294
12.3 REVENUE SHARE ANALYSIS 295
FIGURE 30 REVENUE SHARE ANALYSIS FOR KEY COMPANIES, 2019–2023 (USD MILLION) 295
12.4 MARKET SHARE ANALYSIS 295
FIGURE 31 MICE MODEL MARKET SHARE ANALYSIS OF KEY PLAYERS (2023) 296
TABLE 427 MICE MODEL MARKET: INTENSITY OF COMPETITIVE RIVALRY 296
12.5 FINANCIAL METRICS 297
12.6 BRAND/PRODUCT COMPARATIVE ANALYSIS 298
12.6.1 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY MODEL 298
FIGURE 32 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY MODEL 298
12.6.1.1 CHARLES RIVER LABORATORIES 298
12.6.1.2 THE JACKSON LABORATORY 299
12.6.1.3 INOTIV 299
12.6.1.4 TACONIC BIOSCIENCES, INC. 299
12.6.1.5 BIOCYTOGEN 299
12.6.2 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY SERVICE 300
FIGURE 33 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY SERVICE 300
12.6.2.1 CHARLES RIVER LABORATORIES 300
12.6.2.2 THE JACKSON LABORATORY 300
12.6.2.3 INOTIV 301
12.6.2.4 TACONIC BIOSCIENCES, INC. 301
12.6.2.5 BIOCYTOGEN 301
12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS (2023) 301
12.7.1 STARS 301
12.7.2 EMERGING LEADERS 302
12.7.3 PERVASIVE PLAYERS 302
12.7.4 PARTICIPANTS 302
FIGURE 34 MICE MODEL MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS) 2023, 302
12.7.5 COMPANY FOOTPRINT (KEY PLAYERS) 303
FIGURE 35 MICE MODEL MARKET: COMPANY FOOTPRINT KEY PLAYERS 303
TABLE 428 INDUSTRY FOOTPRINT (KEY PLAYERS) 304
12.7.6 PRODUCT & SERVICE FOOTPRINT 305
TABLE 429 MICE MODEL MARKET: PRODUCT & SERVICE FOOTPRINT (KEY PLAYERS) 305
12.7.7 REGIONAL FOOTPRINT (KEY PLAYERS) 306
TABLE 430 REGIONAL FOOTPRINT (KEY PLAYERS) 306
12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES 307
12.8.1 PROGRESSIVE COMPANIES 307
12.8.2 RESPONSIVE COMPANIES 307
12.8.3 DYNAMIC COMPANIES 307
12.8.4 STARTING BLOCKS 307
FIGURE 36 MICE MODEL MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 308
12.8.5 COMPETITIVE BENCHMARKING OF STARTUPS/SMES 309
TABLE 431 MICE MODEL MARKET: KEY STARTUPS/SMES 309
TABLE 432 MICE MODEL MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 310
12.9 COMPETITIVE SCENARIO 310
12.9.1 PRODUCT LAUNCHES 310
TABLE 433 MICE MODEL MARKET: PRODUCT LAUNCHES, JANUARY 2021−JANUARY 2024 310
12.9.2 DEALS 311
TABLE 434 MICE MODEL MARKET: DEALS, JANUARY 2021−JANUARY 2024 311
12.9.3 EXPANSIONS 312
TABLE 435 MICE MODEL MARKET: EXPANSIONS, JANUARY 2021−JANUARY 2024 312
13 COMPANY PROFILES 313
13.1 KEY PLAYERS 313
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
13.1.1 CHARLES RIVER LABORATORIES 313
TABLE 436 CHARLES RIVER LABORATORIES: BUSINESS OVERVIEW 313
FIGURE 37 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2022) 314
TABLE 437 CHARLES RIVER LABORATORIES: PRODUCTS/SERVICES OFFERED 314
TABLE 438 CHARLES RIVER LABORATORIES: DEALS 317
TABLE 439 CHARLES RIVER LABORATORIES: EXPANSIONS 318
13.1.2 INOTIV 319
TABLE 440 INOTIV: BUSINESS OVERVIEW 319
TABLE 441 INOTIV: PRODUCTS/SERVICES OFFERED 321
TABLE 442 INOTIV: PRODUCT LAUNCHES 323
TABLE 443 INOTIV: DEALS 323
TABLE 444 INOTIV: EXPANSIONS 325
13.1.3 THE JACKSON LABORATORY 326
TABLE 445 THE JACKSON LABORATORY: BUSINESS OVERVIEW 326
TABLE 446 THE JACKSON LABORATORY: PRODUCTS/SERVICES OFFERED 327
TABLE 447 THE JACKSON LABORATORY: PRODUCT LAUNCHES 331
TABLE 448 THE JACKSON LABORATORY: DEALS 332
13.1.4 SHANGHAI MODEL ORGANISMS CENTER, INC. 333
TABLE 449 SHANGHAI MODEL ORGANISMS CENTER, INC.: BUSINESS OVERVIEW 333
FIGURE 40 SHANGHAI MODEL ORGANISMS CENTER, INC.: COMPANY SNAPSHOT (2022) 333
TABLE 450 SHANGHAI MODEL ORGANISMS CENTER, INC.: PRODUCTS/SERVICES OFFERED 334
13.1.5 JSR CORPORATION 336
TABLE 451 JSR CORPORATION: BUSINESS OVERVIEW 336
FIGURE 41 JSR CORPORATION: COMPANY SNAPSHOT (2022) 337
TABLE 452 JSR CORPORATION: PRODUCTS/SERVICES OFFERED 337
TABLE 453 JSR CORPORATION: DEALS 339
13.1.6 BIOCYTOGEN 340
TABLE 454 BIOCYTOGEN: BUSINESS OVERVIEW 340
FIGURE 42 BIOCYTOGEN: COMPANY SNAPSHOT (2022) 341
TABLE 455 BIOCYTOGEN: PRODUCTS/SERVICES OFFERED 341
TABLE 456 BIOCYTOGEN: PRODUCT LAUNCHES 342
TABLE 457 BIOCYTOGEN: DEALS 343
TABLE 458 BIOCYTOGEN: EXPANSIONS 343
13.1.7 TRANS GENIC INC. 344
TABLE 459 TRANS GENIC INC.: BUSINESS OVERVIEW 344
FIGURE 43 TRANS GENIC INC.: COMPANY SNAPSHOT (2023) 344
TABLE 460 TRANS GENIC, INC.: PRODUCTS/SERVICES OFFERED 345
13.1.8 HARBOUR BIOMED 346
TABLE 461 HARBOUR BIOMED: BUSINESS OVERVIEW 346
FIGURE 44 HARBOUR BIOMED: COMPANY SNAPSHOT (2022) 346
TABLE 462 HARBOUR BIOMED: PRODUCTS/SERVICES OFFERED 347
TABLE 463 HARBOUR BIOMED: OTHER DEVELOPMENTS 347
13.1.9 GENOWAY 348
TABLE 464 GENOWAY: BUSINESS OVERVIEW 348
FIGURE 45 GENOWAY: COMPANY SNAPSHOT (2022) 348
TABLE 465 GENOWAY: PRODUCTS/SERVICES OFFERED 349
TABLE 466 GENOWAY: DEALS 351
13.1.10 GEMPHARMATECH 352
TABLE 467 GEMPHARMATECH: BUSINESS OVERVIEW 352
TABLE 468 GEMPHARMATECH: PRODUCTS/SERVICES OFFERED 352
TABLE 469 GEMPHARMATECH: DEALS 354
TABLE 470 GEMPHARMATECH: EXPANSIONS 354
13.1.11 CYAGEN 355
TABLE 471 CYAGEN: BUSINESS OVERVIEW 355
TABLE 472 CYAGEN: PRODUCTS/SERVICES OFFERED 355
13.1.12 OZGENE PTY LTD. 357
TABLE 473 OZGENE PTY LTD.: BUSINESS OVERVIEW 357
TABLE 474 OZGENE PTY LTD.: PRODUCTS/SERVICES OFFERED 357
TABLE 475 DEALS 358
13.1.13 TACONIC BIOSCIENCES, INC. 359
TABLE 476 TACONIC BIOSCIENCES, INC.: BUSINESS OVERVIEW 359
TABLE 477 TACONIC BIOSCIENCES, INC.: PRODUCTS/SERVICES OFFERED 359
TABLE 478 TACONIC BIOSCIENCES, INC.: PRODUCT LAUNCHES 361
TABLE 479 TACONIC BIOSCIENCES, INC.: DEALS 362
13.1.14 TRANSCURE BIOSERVICES 363
TABLE 480 TRANSCURE BIOSERVICES: BUSINESS OVERVIEW 363
TABLE 481 TRANSCURE BIOSERVICES: PRODUCTS/SERVICES OFFERED 363
13.1.15 MARSHALL BIORESOURCES 364
TABLE 482 MARSHALL BIORESOURCES: BUSINESS OVERVIEW 364
TABLE 483 MARSHALL BIORESOURCES: PRODUCTS/SERVICES OFFERED 364
13.1.16 VIVO BIO TECH LTD. 365
TABLE 484 VIVO BIO TECH LTD.: BUSINESS OVERVIEW 365
FIGURE 46 VIVO BIO TECH LTD: COMPANY SNAPSHOT (2022) 365
TABLE 485 VIVO BIO TECH LTD.: PRODUCTS/SERVICES OFFERED 366
13.1.17 INGENIOUS TARGETING LABORATORY 367
TABLE 486 INGENIOUS TARGETING LABORATORY: BUSINESS OVERVIEW 367
TABLE 487 INGENIOUS TARGETING LABORATORY: PRODUCTS/SERVICES OFFERED 367
13.1.18 JANVIER LABS 369
TABLE 488 JANVIER LABS: BUSINESS OVERVIEW 369
TABLE 489 JANVIER LABS: PRODUCTS/SERVICES OFFERED 369
13.2 OTHER PLAYERS 372
13.2.1 APPLIED STEMCELL 372
TABLE 490 APPLIED STEMCELL: BUSINESS OVERVIEW 372
13.2.2 CREATIVE ANIMODEL 373
TABLE 491 CREATIVE ANIMODEL: BUSINESS OVERVIEW 373
13.2.3 JOINN LABORATORIES (CHINA) CO., LTD. 374
TABLE 492 JOINN LABORATORIES (CHINA) CO., LTD.: BUSINESS OVERVIEW 374
13.2.4 CREATIVE BIOLABS 375
TABLE 493 CREATIVE BIOLABS: BUSINESS OVERVIEW 375
13.2.5 CRESCENDO BIOLOGICS 376
TABLE 494 CRESCENDO BIOLOGICS: BUSINESS OVERVIEW 376
13.2.6 ARAGEN LIFE SCIENCES 377
TABLE 495 ARAGEN LIFE SCIENCES: BUSINESS OVERVIEW 377
13.2.7 POLYGENE 378
TABLE 496 POLYGENE: BUSINESS OVERVIEW 378
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
14 APPENDIX 379
14.1 DISCUSSION GUIDE 379
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 383
14.3 CUSTOMIZATION OPTIONS 385
14.4 RELATED REPORTS 385
14.5 AUTHOR DETAILS 386

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のマウスモデル市場（～2029年）：モデルタイプ別（近交系、異系交配、ハイブリッド）、サービス別（育種、再誘導）、技術別（マイクロインジェクション、CRISPR/Cas9）、治療分野別（腫瘍、神経、免疫）、用途別（研究、創薬）(Mice Model Market by Model Types (Inbred, Outbred, Hybrid), Services (Breeding, Rederivation), Technology (Microinjection, CRISPR/Cas9), Therapeutic Area (Oncology, Neurology, Immunology), Application (Research, Drug Discovery) - Global Forecast to 2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp